Chemours turns to euros as it reprices $1.5bn term loan 'B'

Chemours, the listed US chemicals firm spun out of DuPont in 2015, held a lender call on Monday afternoon for a $350m-equivalent euro term loan to repay some of its existing dollar loan.

  • By Max Bower
  • 20 Mar 2017

The Wilmington, Delaware-based firm also wants to reprice its $1.5bn seven year term loan ‘B’, signed in 2015, after its $3bn spin-out from DuPont. The original margin was 300bp with a 0.75% Libor floor.

Price talk for the dollar repricing of 250bp with a 0% floor was released after ...

Please take a trial or subscribe to access this content.

Contact Mark Goodes to discuss your access: mark.goodes@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 20 Mar 2017
1 Bank of America Merrill Lynch 3,452.47 11 8.55%
2 Goldman Sachs 3,349.08 10 8.29%
3 JPMorgan 3,343.06 8 8.28%
4 Credit Suisse 2,505.48 12 6.20%
5 Deutsche Bank 2,382.73 14 5.90%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • 21 Mar 2017
1 Citi 2,417.98 11 10.88%
2 Deutsche Bank 2,229.13 17 10.03%
3 Bank of America Merrill Lynch 1,908.90 13 8.59%
4 JPMorgan 1,733.98 11 7.80%
5 Barclays 1,569.70 11 7.06%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 21 Mar 2017
1 JPMorgan 11,150.67 77 12.59%
2 Citi 8,073.45 55 9.11%
3 Bank of America Merrill Lynch 7,652.39 65 8.64%
4 Goldman Sachs 6,155.05 45 6.95%
5 Credit Suisse 5,502.63 40 6.21%